All filters
Abstracts
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1-infected adult patients in German routine clinical practice – 12-month results of the BICSTaR cohort
C. Stephan
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Feasibility And Efficacy Assessment Of Hepatitis B Vaccination Among Adult Plwh And Vulnerable Population In Vinnytsia Region, Ukraine
T. Melnyk
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Hepatotoxicity And The Hepatic Panel Analysis Among HIV-Positive Ukrainian Patients Receiving Efaverentz And Dolutegravir-Containing Modes
A. Kiurdzhyieva
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Natural Course Of Hepatitis C Virus Infection: Which Factors Affect Spontaneous Clearance Of HCV Among The Ukrainian Population?
N. Zhandarova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Effectiveness And Tolerability Of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) In HIV-1-Infected Adult Patients In German Routine Clinical Practice – 12-Month Results Of The BICSTaR Cohort
M. Heinzkill
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Long-Acting Cabotegravir + Rilpivirine For HIV Treatment: Flair Week 96 Results
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dual Therapy Including Dolutegravir Plus Boosted-Darunavir Ensures High Rate Of Virological Control And Rare Resistance Selection At Failure In Heavily Treatment Experienced PLWH
D. Armenia
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Real-World Effectiveness Of Elbasvir/Grazoprevir In The Treatment Of Patients With Hepatitis C Virus Genotype 1A Infection In Norway
R. A. Leiva
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dual Therapy With Dolutegravir Plus Lamivudine In Virologically Suppressed Patients
C. I. Simoes Valente
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HIV A1 Or B Do Not Differentially Impact Cabotegravir In Vitro Potency Or Durability
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Molecular Epidemiology Of The HIV-1 Infection In Cyprus (2017-2019): A Polyphyletic Infection With An Increasing Prevalence Of Drug Resistance
L. Kostrikis
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HIV Evolution In Patients Initiating Antiretroviral Therapy During Primary Infection
B. Abdi
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
A Changing Of HIV-1 Genetic Diversity In Russia During The Last Two Decades: Increase Of The Recombinants Prevalence
A. Antonova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Unexpected Rising In The Circulation Of Complex HBV Variants Enriched Of HBsAg Vaccine-Escape Mutations In HBV Genotype-D: Potential Impact On HBsAg Detection/Quantification And Vaccination Strategies
M. Alkhatib
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Residual Phenotypic Susceptibility To Second Generation Nnrti In Multidrug Resistant HIV-1 From The Prestigio Registry
F. Saladini
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Susceptibility To HIV-1 Integrase Inhibitors In HIV-1 Sub-Subtype A6 Isolates
A. Giannini
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Two-Drug Regimen (2DR) For Initial HIV Treatment? – Lessons Learned From 20 Years Resina Cohort
N. Lübke
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Transmitted Drug Resistance To Integrase Based First-Line HIV Antiretroviral Treatment In The MeditRes HIV Collaboration
F. García
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dynamics Of HIV-1 Transmission Clusters In North And Central Italy Over The Years 2012-2019
R. Scutari
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Exploring Molecular Characteristics And Evolutionary Dynamics Of The HIV-1 Epidemic In Montenegro Through Phylogenetic Analyses
S. Dragas
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence And Spatiotemporal Dynamics Of The HIV-1 Circulating Recombinant Form 03_AB (CRF03_AB) In The Former Soviet Union
E. Ozhmegova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Short- And Long-Term Direct Medical Costs Of Late And Very Late HIV Presentation
L. Versteegh
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Cabotegravir + Rilpivirine Every 2 Months Is Noninferior To Monthly: ATLAS-2M Study
P. Benn
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Treatment Outcome Among People Living With Hiv Starting First-Line Rapid Or GRT Guided ART From 2015 To 2018
A. De Vito
Presented at:
European Meeting on HIV & Hepatitis 2020